Percutaneous carotid artery stenting: a strategy in evolution.

Carotid artery stenosis remains a major cause of stroke. Surgical endarterectomy has long been the standard treatment, but not all patients are suitable surgical candidates. Some patients face high surgical risks due to age, comorbidities, or anatomical factors. Alternative percutaneous interventions have been explored for these individuals. Carotid stenting was first introduced for patients who could not tolerate surgery. Over time, the procedure has expanded to include patients with standard surgical risk profiles. Prior research has shown that stenting can reduce stroke risk in high-risk groups. However, the long-term effectiveness and safety of stenting in broader populations remain uncertain. This gap motivated the need for detailed outcome studies across diverse patient groups.

The aim of this study was to evaluate the clinical outcomes of carotid stenting in a consecutive patient cohort. Researchers wanted to assess the feasibility and safety of the procedure in a real-world setting. They focused on both short-term and long-term outcomes to better understand its role in stroke prevention. The study included patients from December 1997 to July 2003 at a single institution. The authors sought to determine whether stenting could be a reliable alternative to surgery. They also examined the use of distal protection devices and their impact on outcomes. The motivation stemmed from the growing interest in stenting as a less invasive option. The study aimed to provide evidence-based guidance for clinical decision-making.

The study followed a cohort of 111 patients who underwent carotid stenting between December 1997 and July 2003. Researchers collected data on peri-procedural and long-term outcomes. Stents were placed in 118 carotid arteries, with success rates recorded for each procedure. Distal protection devices were used in 36.4% of cases to reduce embolic risk. The team tracked complications such as stroke, death, and myocardial infarction. Long-term follow-up was conducted for 91% of patients over a mean of 27.1 months. Survival rates free of stroke or stent failure were estimated using the Kaplan-Meier method. The study design allowed for a detailed analysis of both procedural and post-procedural outcomes.

Stents were successfully placed in 117 out of 118 carotid arteries, with a success rate of 99.2%. The peri-procedural rate of death or disabling stroke was 2.5%. Death or any stroke occurred in 9.3% of cases, but only 5.9% resulted in persistent neurological deficits. No myocardial infarctions were reported. The median hospital stay after the procedure was one day. Long-term follow-up was available for 91% of patients. At 36 and 66 months, the survival rate free of ipsilateral stroke was 77.0% and 68.2%, respectively. The estimated survival free of any stroke or stent failure was 70.9% and 60.7%, respectively. Most late deaths were attributed to cardiac causes.

The authors conclude that carotid stenting is a feasible and safe procedure with a high success rate. The low complication rate supports its use in high-risk patients who may not tolerate surgery. The findings suggest that stenting can be considered the preferred option for such individuals. The use of distal protection devices appears to contribute to favorable outcomes. However, the study does not claim that stenting is superior to surgery in all cases. The authors emphasize the importance of patient selection and procedural technique. They do not propose stenting as a replacement for endarterectomy in all patients. Instead, they recommend it as a viable alternative for those who are not surgical candidates.